RecruitingNot ApplicableNCT06250712
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Sponsor
Wonju Severance Christian Hospital
Enrollment
588 participants
Start Date
Feb 22, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.
Eligibility
Min Age: 19 Years
Inclusion Criteria2
- Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
- Patients who can use a smartphone
Exclusion Criteria2
- Patients who have cardiac implantable electronic devices(CIEDs)
- Patients who can't use handheld ECG
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEContinous ECG Patch
Using a continuous patch ECG for 1 week during 1 month
DEVICEIntermittent handheld ECG
Using a handheld ECG twice daily and when symptoms are present during 1 month
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06250712
Related Trials
DiamondTemp Global Registry
NCT0473501621 locations
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
NCT007335904 locations
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180318 locations
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
NCT070969731 location
Genetics of Cardiovascular and Neuromuscular Disease
NCT001389311 location